Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, central Slovenia, 2006 to 2014

Eurosurveillance

Volumn 20, Issue 37, 2015, Pages

  Kogoj, R ^a   Mrvic, T ^b   Praprotnik, M ^c   Kese, Darja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; ANTIINFECTIVE AGENT; BACTERIAL DNA; RNA 23S;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CHILD; FEMALE; GENOTYPE; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; MALE; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SLOVENIA; UPPER RESPIRATORY TRACT INFECTION; DRUG EFFECTS; GENETICS; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, MYCOPLASMA; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INFANT; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 23S; SLOVENIA; YOUNG ADULT;

EID: 85003048532     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2015.20.37.30018     Document Type: Article

References (47)

1. Hammerschlag MR. Mycoplasma pneumoniae infections. Curr Opin Infect Dis. 2001;14(2):181-6. DOI:10.1097/00001432-200104000-00012 PMID:11979130
2. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32(6):956-73. DOI:10.1111/1.1574-6976.2008.00129.x PMID:18754792
3. Mclntosh K. Community-acquired pneumonia in children. N Engl J Med. 2002;346(6):429-37. DOI:10.1056/NEJMra011994 PMID:11832532
4. Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med. 2008;102(12):1762-8. DOI:10.1016/j.rmed.2008.06.022 PMID:18703327
5. Howard LS, Sillis M, Pasteur MC, Kamath AV, Harrison BD. Microbiological profile of community-acquired pneumonia in adults over the last 20 years. J Infect. 2005;50(2):107-13. DOI:10.1016/j.jinf.2004.05.003 PMID:15667910
6. Miyashita N, Ouchi K, Kawasaki K, Oda K, Kawai Y, Shimizu H, et al. Mycoplasma pneumoniae pneumonia in the elderly. Med Sci Monit. 2008;14(8):CR387-91. PMID: 18667994
7. Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J. 2009;28(8):693-6. DOI:10.1097/INF.0b013e31819e3f7a PMID:19633515
8. Rasmussen JN, Voldstedlund M, Andersen RL, Ellermann-Eriksen S, Jensen TG, Johansen HK, et al. Increased incidence of Mycoplasma pneumoniae infections detected by laboratory- based surveillance in Denmark in 2010. Euro Surveill. 2010;15(45):19708. PMID: 21087593
9. Chalker V, Stocki T, Mentasti M, Fleming D, Harrison T. Increased incidence of Mycoplasma pneumoniae infection in England and Wales in 2010: multiocus variable number tandem repeat analysis typing and macrolide susceptibility. Euro Surveill. 2011;16(19):19865. PMID: 21596009
10. Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period.J Infect. 2008;56(5):326-31. DOI:10.1016/j.jinf.2008.02.018 PMID:18420275
11. Pereyre S, Charron A, Renaudin H, Bebear C, Bebear CM. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol. 2007;45(11):3534-9. DOI:10.1128/JCM.01345-07 PMID:17881549
12. Cousin A, Bertille DB, Alain C, Helene R, Christiane B. Analysis of RFLPs amplified cytadhesin P1 gene for epidemiological study of Mycoplasma pneumoniae. In: Programme and abstracts of the 10th International Congress of the International Organisation for Mycoplasmology (IOM). 1994; p. 494-5.
13. Dorigo-Zetsma JW, Dankert J, Zaat SA. Genotyping of Mycoplasma pneumoniae clinical isolates reveals eight P1 subtypes within two genomic groups. J Clin Microbiol. 2000;38(3):965-70. PMID: 10698981
14. Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Molvadgaard M, Fons Petersen R, et al. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 2012;17(5):20073. PMID: 22321137
15. Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2010;16(6):613-6. DOI:10.nn/j.1469-0691.2009.02968.x PMID:19765022
16. Chironna M, Sallustio A, Esposito S, Perulli M, ChinellatoI, Di Bari C, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011;66(4):734-7. DOI:10.1093/jac/dkr003 PMID:21393214
17. Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009;64(1):52-8. DOI:10.1093/jac/dkp160 PMID:19429926
18. Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis. 2011;17(6):1079-82. DOI:10.3201/eid/1706.101558 PMID:21749775
19. Yamada M, Buller R, Bledsoe S, Storch GA. Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J. 2012;31(4):409-10. DOI:10.1097/INF.0b013e318247f3e0 PMID:22209916
20. Acute Respiratory Diseases Study Group, Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother. 2008;52(1):348-50. DOI:10.1128/AAC.00779-07 PMID:17954691
21. Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010;51(2):189-94. DOI:10.1086/653535 PMID:20540621
22. Xin D, Mi Z, Han X, Qin L, Li J, Wei T, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother. 2009;53(5):2158-9. DOI:10.1128/AAC.01563-08 PMID: 19273685
23. Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother. 2009;53(5):2160-2. DOI:10.1128/AAC.01684-08 PMID: 19273684
24. Zhao F, Lv M, Tao X, Huang H, Zhang B, Zhang Z, et al. Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China. Antimicrob Agents Chemother. 2012;56(2):1108-9. DOI:10.1128/AAC.05627-11 PMID:22106216
25. Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, et al. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Respirology. 2012;17(2):354-62. DOI:10.1111/j.1440-1843.2011.02102.x PMID:22077195
26. Bebear CM, Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr Drug Targets Infect Disord. 2005;5(3):263-71. DOI:10.2174/1568005054880109 PMID:16181145
27. Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010;16(2):78-86. DOI:10.1007A10156-009-0021-4 PMID:20094751
28. Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis. 2010;67(4):355-8. DOI:10.1016/j.diagmicrobio.2010.03.004 PMID:20638604
29. Socan M, Marinic-Fiser N, Kraigher A, Kotnik A, Logar M. Microbial aetiology of community-acquired pneumonia in hospitalised patients. Eur J Clin Microbiol Infect Dis. 1999;18(11):777-82. DOI:10.1007/100960050400 PMID:10614951
30. Beovic B, Bonac B, Kese D, Avsic-Zupanc T, Kreft S, Lesnicar G, et al. Aetiology and clinical presentation of mild community- acquired bacterial pneumonia. Eur J Clin Microbiol Infect Dis. 2003;22(10):584-91. DOI:10.1007/s10096-003-0997-0 PMID:13680399
31. Population, statistical regions, Slovenia, annualy. Republic of Slovenia Statistical office RS. [Accessed 24 Jun 2015]. Available from: http://pxweb.stat.si/pxweb/Dialog/varval.asp?ma=05C2002E&ti=&path=../Database/Demographics/05_population/10_Number_Population/10_05C20_Population_stat_regije/&lang=i
32. Waites KB, Rikihisa Y, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical microbiology 8th edition. Washington DC: American Society for Microbiology Press; 2003. p. 972-90.
33. Pereyre S, Guyot C, Renaudin H, Charron A, Bebear C, Bebear CM. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2004;48(2):460-5. DOI:10.1128/AAC.48.2.460-465.2004 PMID:14742195
34. Himmelreich R, Hilbert H, Plagens H, Pirkl E, Li B C, Herrmann R. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.Nucleic Acids Res. 1996: 24(22):4420-49. DOI:i0.i093/nar/24.22.4420 PMID:8948633
35. Schwartz SB, Mitchell SL, Thurman KA, Wolff BJ, Winchell JM. Identification of Pi variants of Mycoplasma pneumoniae by use of high-resolution melt analysis. J Clin Microbiol. 2009;47(12):4117-20. DOI:10.1128/JCM.01696-09 PMID:19828737
36. Lin C, Li S, Sun H, Zhao H, Feng Y, Cao L, et al. Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China. J Clin Microbiol. 2010;48(12):4567-72. DOI:10.1128/JCM.00400-10 PMID:20861333
37. Sasaki T, Kenri T, Okazaki N, Iseki M, Yamashita R, Shintani M, et al. Epidemiological study of Mycoplasma pneumoniae infections in japan based on PCR-restriction fragment length polymorphism of the Pi cytadhesin gene. J Clin Microbiol. 1996;34(2):447-9. PMID: 8789036
38. Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48(12):4624-30. DOI:10.1128/AAC.48.12.4624-4630.2004 PMID:15561835
39. Zhao F, Cao B, Li J, Song S, Tao X, Yin Y, et al. Sequence analysis of the pi adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009. J Clin Microbiol. 2011;49(8):3000-3. DOI:10.1128/JCM.00105-11 PMID:21697320
40. Spuesens EB, Hoogenboezem T, Sluijter M, Hartwig NG, van Rossum AM, Vink C. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J Microbiol Methods. 2010;82(3):214-22. DOI:10.1016/j.mimet.2010.06.004 PMID:20547188
41. Spuesens EB, Meijer A, Bierschenk D, Hoogenboezem T, Donker GA, Hartwig NG, et al. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands. J Clin Microbiol. 2012;50(6):1999-2004. DOI:10.1128/JCM.00400-12 PMID:22495561
42. European Working Group on Mycoplasma pneumoniae surveillance, Lenglet A, Herrador Z, Magiorakos AP, Leitmeyer K, Coulombier D. Surveillance status and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012. Euro Surveill. 2012;17(5):20075. PMID: 22321134
43. Kenri T, Okazaki N, Yamazaki T, Narita M, Izumikawa K, Matsuoka M, et al. Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: type shift phenomenon of M. pneumoniae clinical strains. J Med Microbiol. 2008;57(Pt 4): 469-75. DOI:10.1099/jmm.0.47634-0 PMID:18349367
44. Diaz MH, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53(1):124-30. DOI:10.1128/JCM.02597-14 PMID:25355769
45. Pereyre S, Charron A, Hidalgo-Grass C, Touati A, Moses AE, Nir-Paz R, et al. The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS ONE. 2012; 7(6):e38585. DOI:10.1371/journal.pone.0038585 PMID:22701675
46. Pecar-Cad S, Hribovsek T. 2012. Ambulantno predpisovanje zdravil v sloveniji po ACT klasifikaciji v letu 2011. [Outpatient prescription drugs in Slovenia according to The Anatomical Therapeutic Chemical (ATC) Classification System in 2011]. Ljubljana: Institut za varovanje zdravja republike Slovenije. [Accessed 7 Oct 2014]. Slovenian. Available from: http://www.nijz.si/sites/www.nijz.si/files/publikacije-datoteke/ambulantno_predpisovanje_zdravil_v_slo_po_atc_klasifikaciji_2011.pdf
47. The European Surveillance System (TESSy) - Distribution of antimicrobial consumption by antimicrobial group. Stockholm: European Centre for Disease Prevention and Control. [Accessed 22 Jun 2015]. Available from: http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/esac-net-database/Pages/consumption-rates-by-country.aspx